Stroke Journal

FEBRUARY 1, 2024

Background:Utilizing medical claims derived information, we evaluated temporal trends in post-acute care utilization pathways among patients with acute ischemic stroke (AIS) or intracerebral hemorrhage (ICH).Methods:Data Analytical sample included all Medicare enrollees with a primary discharge diagnosis (AIS or ICH) from 2016 to 2020.

Medicare 40

Medicare Hemorrhage Inpatient Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Medicare) have a lower risk of r-ICH (0.45, 0.31 - 0.67), AIS (0.71, 0.53 - 0.95), and MACE (0.58, 0.47 - 0.71). Patients with lobar ICH (vs. non-lobar ICH) had a higher risk of r-ICH (SHR, CI: 1.67, 1.35 - 2.07) and MACE (1.28, 1.14 - 1.44). Blacks (vs. Whites) have a higher risk of AIS (1.64, 1.32 - 2.03) and MACE (1.42, 1.22 - 1.65).

Hemorrhage 40

Hemorrhage Myocardial Infarction Atrial Fibrillation Medicare 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Cerebral amyloid angiopathy (CAA) is associated with multiple conditions that are known to have an elevated risk of seizures, including intracerebral hemorrhage, CAA-related inflammation, and Alzheimer’s disease. In Cox proportional hazards analysis, CAA was associated with an increased risk of seizures (HR, 12.6;

Medicare 40

Medicare Outpatient Inpatient Hemorrhage 40